PharmSci 360 is built on six tracks that offer both chemical and biomolecular drug programming in symposia, rapid fire presentations, and posters.
Discovery on Target (DOT) highlights advances in current and emerging "hot"; targets and technologies. This 20th Annual event brings back popular topics like PROTACs and RNA plus new programming on immunomodulation, antivirals, neurodegeneration targets, KRAS, and AI.
Cell & Gene Therapy Manufacturing & Commercialization US 2022, a hybrid event co-located with BioProcess International, is to be delivered at the Boston Convention and Exhibition Center during September 27-30, 2022.
Now in its eighteenth year, the PEGS Boston Summit is recognized as the leading international meeting place for the biotherapeutics community.